Microalgae as a source of bioactive molecules - Experience from cyanophyte research

Journal of Applied Phycology

Volumn 12, Issue 3-5, 2000, Pages 341-348

  Skulberg, Olav M ^a  

^a NORWEGIAN INSTITUTE FOR WATER RESEARCH   (Norway)

Author keywords

Antibiotic activity; Cyanophytes; New compounds; Prospectives; Screening; Secondary metabolites

Indexed keywords

ANTIBACTERIAL ACTIVITY; BIOACTIVE MOLECULE; BIOLOGICAL ACTIVITY; BIOSYNTHESIS; CYANOPHYTE; DRUG MANUFACTURE; GENETIC SCREENING; MICROALGA; TOXIN;

EID: 0033745304     PISSN: 09218971     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1008140403621     Document Type: Conference Paper

References (56)

1. Enhancement of acetylcholine release by homoanatoxin-a from Oscillatoria formosa
2. Looking glass chemistry
3. Tenuecyclamides A-D, cyclic hexapeptides from the cyanobacterium Nostoc spongiaeforme var. tenue
4. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: Potential applications to microbicide development
5. Comparative assessment of the specificity of the brine shrimp and Microtox assays to hepatotoxic (microcystin-LR-containing) cyanobacteria
6. Cyanobacteria secondary metabolites - The cyanotoxins
7. Inhibition of Candida albicans and Staphylococcus aureus by phenolic compounds from the terrestrial cyanobacterium Nostoc muscorum
8. Antibacterial and cytotoxic compounds from the blue-green alga Fischerella ambigua
9. Biological activities of cyanobacteria: Evaluation of extracts and pure compounds
10. Comparative study of toxic and non-toxic cyanobacterial products: Novel peptides from toxic Nodularia spumigena A V1
11. Biotechnological potential of microalgae
12. AIDS-antiviral sulfolipids from cyanobacteria (blue-green algae)
13. Fischerellin A, a novel photosystem-II-inhibiting allelochemical of the cyanobacterium Fischerella muscicola with antifungal and herbicidal activity
14. Symplostatin 1: A dolastin 10 analogue from the marine cyanobacterium Symploca hydnoides
15. Isolation, structure determination, and biological activity of dolastatin 12 and lyngbyastatin 1 from Lyngbya majuscula/Schizothrix calcicola cyanobacterial assemblages
16. Rapid analysis of cyanophyte neurotoxins: An improved method for quantitative analysis of anatoxin-a and homoanatoxin-a in the sub-ppb to ppb range
17. Genetic manipulation of photosynthetic prokaryotes
18. A natural sulfated polysaccharide, calcium spirulan, isolated from Spirulina platensis: In vitro and ex vivo evaluation of anti-herpes simplex virus and anti-human immunodeficiency virus activities
19. Inhibition of Chlorella growth by the lipids of cyanobacterium Microcystis aeruginosa
20. Micropeptins 478-A and -B, plasmid inhibitors from the cyanobacterium Microcystis aeruginosa
21. Microginins 299-A and -B, leucine aminopeptidase inhibitors from the cyanobacterium Microcystis aeruginosa (NIES-299)
22. Kawaguchipeptin B, an antibacterial cyclic undecapeptide from the cyanobacterium Microcystis aeruginosa
23. Sensitive determination of anatoxin-a, homoanatoxin-a and their degradation products by liquid chromatography with fluorimetric detection
24. Nurturing nature: Engineering new antibiotics
25. Potential and commercial applications for photosynthetic prokaryotes
26. Search for bioactive substances from marine microalgae and cyanobacteria
27. Dehydroradiosumin a trypsin inhibitor from the cyanobacterium Anabaena cylindrica
28. Assessment of rapid bioassays for detecting cyanobacterial toxicity
29. Neurotoxins and neurodegenerative disease
30. Carbolines from the blue-green alga Dichothrix baueriana
31. Effects of homoanatoxin-a containing extract from Oscillatoria formosa (Cyanophyceae/Cyanobacteria) on neuromuscular transmission
32. The inhibition of the reverse transcritase of HIV-1 by the natural sulfoglycolipids from cyanobacteria: Contribution of different moieties to their high potency
33. Aeruginosins 102-A and B, new thrombin inhibitors from the cyanobacterium Microcystis viridis (NIES-102)
34. Micropeptin 103, a chymotrypsin inhibitor from the cyanobacterium Microcystis viridis (NIES-103)
35. Microviridins, elastase inhibitors from the cyanobacterium Nostoc minutum (NIES-26)
36. A cyclic peptide, anabaenopeptin B, from the cyanobacterium Oscillatoria agardhii
37. Bioactive compounds produced by cyanobacteria
38. Antiviral activity of an aqueous extract of the cyanobacterium Microcystis aeruginosa
39. Dendroamides, new cyclic hexapeptides from a blue-green alga. Multidrug-resistance reversing activity of dendroamide A
40. Nostopeptins A anti B, elastase inhibitors from the cyanobacterium Nostoc minutum
41. Antibacterial properties of extracts from selected planktonic freshwater cyanobacteria - A comparative study of bacterial bioassays
42. Fungal cell-wall polysaccharides elicit an antifungal secondary metabolite (phytoalexin) in the cyanobacterium Scytonema ocellatum
43. New acetylated sulfoglycolipids and digalactolipids and related known glycolipids from cyanobacteria with potential to inhibit the reverse transcriptase of HIV-1
44. Toxic blue-green algae, the 'problem' in perspective
45. Oscillapeptin G, a tryrosinase inhibitor from toxic Oscillatoria agardhii
46. Circinamide, a novel papain inhibitor from the cyanobacterium Anabaena circinalis (NIES-41)
47. Recent natural products based drug development: A pharmaceutical industry perspective
48. Toxins produced by cyanophytes in Norwegian inland waters - Health and environment
49. Investigations of a neurotoxic-oscillatorialean strain (Cyanophyceae) and its toxin. Isolation and characterization of homoanatoxin-a
50. Diversity, ecology and taxonomy of the cyanobacteria
51. Homoanatoxin: A potent analogue of anatoxin-a